Biohacking Market By Manufacturers, By Product (Smart Drugs, Sensors, Strains, Others) By Application (Synthetic Biology, Genetic Engineering, Forensic Science, Diagnosis & Treatment, Drug Testing) By End-user (Pharmaceutical & Biotechnology Companies, Forensic Laboratories, Others), and By Regions (North America, Europe, Middle East and Africa, Latin America and Asia Pacific) - Global Outlook to 2026
Report ID: 391285 | Feb 2020 | No. of Pages: 120
|
Covid-19 Impact Analysis & Forecast
Global Biohacking Market is valued USD 12318.19 Million in 2019 and is projected is to exhibit 19.48% CAGR during the forecast period. The market is projected to be around USD 42816.72 Million by 2026. The market is driven by the advancement of new technologies, and increasing awareness about biohacking.
Biohacking is essentially the use of changing chemistry and physiology through science and self-experimentation to strengthen and enhance the body. Biohackers are people who perform lab experiments to investigate new possibilities of molecular biology, biotechnology, genetic engineering and many other characters of biology.
Biohacking Market Dynamics
The factors that increase the growth of the biohacking market are the advancement of new technologies, increasing awareness about biohacking, rising demand for smart devices and effective drugs, and the growing prevalence of chronic diseases. Furthermore, increasing the use of RFID in medical devices combined with the penetration of the internet of things (IoT) in healthcare, fitness, and consumer electronics sectors is expected to boost the demand for the market.
At the same time, strict regulations that govern the genetic engineering experiments, lack of funds required for research, and lack of expertise as well as cybersecurity practices are expected to hamper the market during the forecast period.
Biohacking Market Insight
Based on the region, Asia Pacific is expected to dominate the market due to the enhancement in different domestic economies is expected to encourage the progress of the market during the forecast period. The development in the healthcare sector and growing investment in it are also expected to make a substantial market move.
Biohacking Market Segmentation
The global biohacking market is segmented into product, application, end-user, and region. On the basis of the product the market is divided into smart drugs, sensors, strains, others. Based on application the market is segmented into synthetic biology, genetic engineering, forensic science, diagnosis & treatment, drug testing. Based on the end-user the market is segmented into pharmaceutical & biotechnology companies, forensic laboratories, others. And based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Biohacking Market Competitive Landscape
The key players in Biohacking Market are listed as Fitbit, Apple, Synbiota, THE ODIN, HVMN, Thync Global, Moodmetric, and Other.
Biohacking is essentially the use of changing chemistry and physiology through science and self-experimentation to strengthen and enhance the body. Biohackers are people who perform lab experiments to investigate new possibilities of molecular biology, biotechnology, genetic engineering and many other characters of biology.
Biohacking Market Dynamics
The factors that increase the growth of the biohacking market are the advancement of new technologies, increasing awareness about biohacking, rising demand for smart devices and effective drugs, and the growing prevalence of chronic diseases. Furthermore, increasing the use of RFID in medical devices combined with the penetration of the internet of things (IoT) in healthcare, fitness, and consumer electronics sectors is expected to boost the demand for the market.
At the same time, strict regulations that govern the genetic engineering experiments, lack of funds required for research, and lack of expertise as well as cybersecurity practices are expected to hamper the market during the forecast period.
Biohacking Market Insight
Based on the region, Asia Pacific is expected to dominate the market due to the enhancement in different domestic economies is expected to encourage the progress of the market during the forecast period. The development in the healthcare sector and growing investment in it are also expected to make a substantial market move.
Biohacking Market Segmentation
The global biohacking market is segmented into product, application, end-user, and region. On the basis of the product the market is divided into smart drugs, sensors, strains, others. Based on application the market is segmented into synthetic biology, genetic engineering, forensic science, diagnosis & treatment, drug testing. Based on the end-user the market is segmented into pharmaceutical & biotechnology companies, forensic laboratories, others. And based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Biohacking Market Competitive Landscape
The key players in Biohacking Market are listed as Fitbit, Apple, Synbiota, THE ODIN, HVMN, Thync Global, Moodmetric, and Other.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. DefinitionChapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & LimitationsChapter 3. Executive SummaryChapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain AnalysisChapter 5. Biohacking Market, By Product
5.1. Biohacking Market, By Product, 2018-2026
5.2. Smart Drugs
5.3. Sensors
5.4. Strains
5.5. Others
5.6. ApplicationChapter 6. Biohacking Market, By Application
6.1. Biohacking Market, by Application, 2018-2026
6.2. Synthetic Biology
6.3. Genetic Engineering
6.4. Forensic Science
6.5. Diagnosis & Treatment
6.6. Drug TestingChapter 7. Biohacking Market, By End-user
7.1. Biohacking Market, by End-user, 2018-2026
7.2. Pharmaceutical & Biotechnology Companies
7.3. Forensic Laboratories
7.4. OthersChapter 8. Biohacking Market, By Region
8.1. Biohacking Market, by Region, 2018-2026
8.1.1. North America
8.1.1.1. U.S
8.1.1.2. Rest of North America
8.1.2. Europe
8.1.2.1. U.K.
8.1.2.2. Germany
8.1.2.3. France
8.1.2.4. Rest of the Europe
8.1.3. Middle East & Africa (MEA)
8.1.3.1. GCC
8.1.3.2. North Africa
8.1.3.3. South Africa
8.1.3.4. Rest of MEA
8.1.4. Latin America (LATAM)
8.1.4.1. Brazil
8.1.4.2. Rest of LATAM
8.1.5. Asia Pacific (APAC)
8.1.5.1. India
8.1.5.2. China
8.1.5.3. Japan
8.1.5.4. Rest of the APACChapter 9. Competitive Landscape
9.1.1. Key Strategies Adopted by Players
9.1.2. Market Share/Positioning AnalysisChapter 10. Company Profiles10.1. Fitbit
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives10.2. Apple
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives10.3. Synbiota
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives10.4. THE ODIN
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives10.5 HVMN
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives10.6. Thync Global
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives10.7. Moodmetric
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives10.13. List of other companies
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent InitiativesChapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
1.1. Research Objective
1.2. Scope of the Study
1.3. DefinitionChapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & LimitationsChapter 3. Executive SummaryChapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain AnalysisChapter 5. Biohacking Market, By Product
5.1. Biohacking Market, By Product, 2018-2026
5.2. Smart Drugs
5.3. Sensors
5.4. Strains
5.5. Others
5.6. ApplicationChapter 6. Biohacking Market, By Application
6.1. Biohacking Market, by Application, 2018-2026
6.2. Synthetic Biology
6.3. Genetic Engineering
6.4. Forensic Science
6.5. Diagnosis & Treatment
6.6. Drug TestingChapter 7. Biohacking Market, By End-user
7.1. Biohacking Market, by End-user, 2018-2026
7.2. Pharmaceutical & Biotechnology Companies
7.3. Forensic Laboratories
7.4. OthersChapter 8. Biohacking Market, By Region
8.1. Biohacking Market, by Region, 2018-2026
8.1.1. North America
8.1.1.1. U.S
8.1.1.2. Rest of North America
8.1.2. Europe
8.1.2.1. U.K.
8.1.2.2. Germany
8.1.2.3. France
8.1.2.4. Rest of the Europe
8.1.3. Middle East & Africa (MEA)
8.1.3.1. GCC
8.1.3.2. North Africa
8.1.3.3. South Africa
8.1.3.4. Rest of MEA
8.1.4. Latin America (LATAM)
8.1.4.1. Brazil
8.1.4.2. Rest of LATAM
8.1.5. Asia Pacific (APAC)
8.1.5.1. India
8.1.5.2. China
8.1.5.3. Japan
8.1.5.4. Rest of the APACChapter 9. Competitive Landscape
9.1.1. Key Strategies Adopted by Players
9.1.2. Market Share/Positioning AnalysisChapter 10. Company Profiles10.1. Fitbit
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives10.2. Apple
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives10.3. Synbiota
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives10.4. THE ODIN
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives10.5 HVMN
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives10.6. Thync Global
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives10.7. Moodmetric
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives10.13. List of other companies
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent InitiativesChapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
Fitbit
Apple
Synbiota
THE ODIN
HVMN
Thync Global
Moodmetric
Other
Apple
Synbiota
THE ODIN
HVMN
Thync Global
Moodmetric
Other
1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market
3. It provides a forward looking perspective on different factors driving or restraining market growth
4. It provides an eight-year forecast assessed on the basis of how the market is expected to grow
5. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segment
6. Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Connect With Us
+1-707-633-0404
sales@search4research.com